Symbols / RPID
RPID Chart
About
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 183.05M |
| Enterprise Value | 146.38M | Income | -44.29M | Sales | 30.52M |
| Book/sh | 1.00 | Cash/sh | 0.95 | Dividend Yield | — |
| Payout | 0.00% | Employees | 163 | IPO | — |
| P/E | — | Forward P/E | -4.79 | PEG | — |
| P/S | 6.00 | P/B | 4.13 | P/C | — |
| EV/EBITDA | -3.45 | EV/Sales | 4.80 | Quick Ratio | 2.87 |
| Current Ratio | 4.23 | Debt/Eq | 11.91 | LT Debt/Eq | — |
| EPS (ttm) | -1.00 | EPS next Y | -0.86 | EPS Growth | — |
| Revenue Growth | 3.10% | Earnings | 2026-03-12 | ROA | -29.84% |
| ROE | -68.83% | ROIC | — | Gross Margin | 7.72% |
| Oper. Margin | -145.09% | Profit Margin | -145.11% | Shs Outstand | 39.82M |
| Shs Float | 18.98M | Short Float | 1.29% | Short Ratio | 0.44 |
| Short Interest | — | 52W High | 4.94 | 52W Low | 1.86 |
| Beta | 1.39 | Avg Volume | 230.78K | Volume | 116.27K |
| Target Price | $8.00 | Recom | None | Prev Close | $3.99 |
| Price | $4.13 | Change | 3.51% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$8.00
Mean price target
2. Current target
$4.13
Latest analyst target
3. DCF / Fair value
$-10.42
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.13
Low
$8.00
High
$8.00
Mean
$8.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-07-28 | init | Lake Street | — → Buy | $8 |
| 2025-02-12 | init | Keybanc | — → Overweight | $8 |
| 2023-03-07 | reit | Morgan Stanley | — → Equal-Weight | $3 |
| 2022-08-16 | down | JP Morgan | Overweight → Neutral | — |
| 2022-05-11 | main | Morgan Stanley | — → Equal-Weight | $8 |
| 2022-03-07 | main | Morgan Stanley | — → Equal-Weight | $10 |
| 2022-02-15 | main | Morgan Stanley | — → Equal-Weight | $11 |
| 2021-11-15 | main | Morgan Stanley | — → Equal-Weight | $24 |
| 2021-08-09 | init | Cowen & Co. | — → Outperform | — |
| 2021-08-09 | init | Morgan Stanley | — → Equal-Weight | $26 |
| 2021-08-09 | init | Stifel | — → Buy | $28 |
| 2021-08-09 | init | JP Morgan | — → Overweight | $30 |
- Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 - Stock Titan ue, 24 Feb 2026 21
- Rapid Micro Biosystems to Announce Q4 and Full Year 2025 Financial Results on March 12, 2026 - Quiver Quantitative ue, 24 Feb 2026 21
- Rapid Micro Biosystems COO sells $21k in shares - Investing.com South Africa Sat, 21 Feb 2026 01
- Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance Fri, 07 Nov 2025 08
- Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable - simplywall.st Sat, 17 Jan 2026 08
- Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire hu, 12 Feb 2026 08
- Top Executives Make Notable Moves in Rapid Micro Biosystems Stock - TipRanks ue, 10 Feb 2026 08
- Will RPID stock benefit from AI adoption - Market Movement Recap & Daily Entry Point Trade Alerts - mfd.ru Sun, 22 Feb 2026 22
- New hires at Rapid Micro Biosystems get 205K RSUs, 168K options - Stock Titan hu, 12 Feb 2026 08
- Insider Sale: CHIEF OPERATING OFFICER of $RPID Sells 4,610 Shares - Quiver Quantitative Wed, 11 Feb 2026 00
- We Think Rapid Micro Biosystems (NASDAQ:RPID) Needs To Drive Business Growth Carefully - Yahoo Finance Sun, 21 Dec 2025 08
- Rapid Micro Biosystems, Inc.'s (NASDAQ:RPID) last week's 10% decline must have disappointed private equity firms who have a significant stake - simplywall.st Fri, 19 Dec 2025 08
- Insider Sale: 10% owner at $RPID Sells 27,500 Shares - Quiver Quantitative Wed, 04 Feb 2026 08
- Rapid Micro Biosystems (NASDAQ: RPID) Q&A set for Nov. 11 at 11:20 a.m. ET, webcast - Stock Titan hu, 30 Oct 2025 07
- Rapid Micro Biosystems COO Wilson sells $17k in stock By Investing.com - Investing.com South Africa Wed, 11 Feb 2026 04
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 17254 | 67687.0 | — | Sale at price 3.92 per share. | WIRTJES SEAN M. CPA | Chief Financial Officer | — | 2026-02-20 00:00:00 | D |
| 1 | 5403 | 21196.0 | — | Sale at price 3.92 per share. | WILSON JOHN J. ADDINGTON | Chief Operating Officer | — | 2026-02-20 00:00:00 | D |
| 2 | 38327 | 148912.0 | — | Sale at price 3.89 per share. | SPIGNESI ROBERT G JR | Chief Executive Officer | — | 2026-02-19 00:00:00 | D |
| 3 | 97000 | — | — | Stock Award(Grant) at price 0.00 per share. | WIRTJES SEAN M. CPA | Chief Financial Officer | — | 2026-02-11 00:00:00 | D |
| 4 | 74000 | — | — | Stock Award(Grant) at price 0.00 per share. | WILSON JOHN J. ADDINGTON | Chief Operating Officer | — | 2026-02-11 00:00:00 | D |
| 5 | 264000 | — | — | Stock Award(Grant) at price 0.00 per share. | SPIGNESI ROBERT G JR | Chief Executive Officer | — | 2026-02-11 00:00:00 | D |
| 6 | 6027 | 22798.0 | — | Sale at price 3.78 per share. | WIRTJES SEAN M. CPA | Chief Financial Officer | — | 2026-02-09 00:00:00 | D |
| 7 | 4610 | 17438.0 | — | Sale at price 3.78 per share. | WILSON JOHN J. ADDINGTON | Chief Operating Officer | — | 2026-02-09 00:00:00 | D |
| 8 | 12840 | 48570.0 | — | Sale at price 3.78 per share. | SPIGNESI ROBERT G JR | Chief Executive Officer | — | 2026-02-09 00:00:00 | D |
| 9 | 49000 | 190091.0 | — | Sale at price 3.88 per share. | LONGITUDE CAPITAL PARTNERS II, LLC | Beneficial Owner of more than 10% of a Class of Security | — | 2026-02-04 00:00:00 | I |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | -6.14M |
| TaxRateForCalcs | 0.21 | 0.21 | 0.01 | 0.27 |
| NormalizedEBITDA | -46.56M | -53.46M | -60.38M | -22.96M |
| TotalUnusualItems | 0.00 | -22.74M | ||
| TotalUnusualItemsExcludingGoodwill | 0.00 | -22.74M | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -46.89M | -52.47M | -60.81M | -73.52M |
| ReconciledDepreciation | 3.36M | 3.10M | 2.84M | 1.53M |
| ReconciledCostOfRevenue | 28.16M | 28.00M | 25.67M | 30.97M |
| EBITDA | -46.56M | -53.46M | -60.38M | -45.70M |
| EBIT | -49.92M | -56.56M | -63.22M | -47.23M |
| NetInterestIncome | 3.16M | 4.21M | 1.78M | -2.61M |
| InterestExpense | 2.65M | |||
| InterestIncome | 3.16M | 4.21M | 1.78M | |
| NormalizedIncome | -46.89M | -52.47M | -60.81M | -56.92M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -46.89M | -52.47M | -60.81M | -73.52M |
| TotalExpenses | 77.97M | 79.08M | 80.35M | 70.46M |
| TotalOperatingIncomeAsReported | -49.92M | -56.56M | -63.22M | -47.23M |
| DilutedAverageShares | 43.58M | 43.02M | 42.45M | 19.78M |
| BasicAverageShares | 43.58M | 43.02M | 42.45M | 19.78M |
| DilutedEPS | -1.08 | -1.22 | -1.43 | -3.94 |
| BasicEPS | -1.08 | -1.22 | -1.43 | -3.94 |
| DilutedNIAvailtoComStockholders | -46.89M | -52.47M | -60.81M | -78.03M |
| NetIncomeCommonStockholders | -46.89M | -52.47M | -60.81M | -78.03M |
| OtherunderPreferredStockDividend | 0.00 | 1.76M | ||
| PreferredStockDividends | 2.75M | |||
| NetIncome | -46.89M | -52.47M | -60.81M | -73.52M |
| NetIncomeIncludingNoncontrollingInterests | -46.89M | -52.47M | -60.81M | -73.52M |
| NetIncomeContinuousOperations | -46.89M | -52.47M | -60.81M | -73.52M |
| TaxProvision | 22.00K | 31.00K | -576.00K | 91.00K |
| PretaxIncome | -46.87M | -52.44M | -61.38M | -73.43M |
| OtherIncomeExpense | -112.00K | -83.00K | 59.00K | -23.59M |
| OtherNonOperatingIncomeExpenses | -112.00K | -83.00K | 59.00K | -850.00K |
| SpecialIncomeCharges | 0.00 | -3.10M | ||
| OtherSpecialCharges | 3.10M | |||
| GainOnSaleOfSecurity | -19.64M | |||
| NetNonOperatingInterestIncomeExpense | 3.16M | 4.21M | 1.78M | -2.61M |
| TotalOtherFinanceCost | -1.78M | 2.61M | ||
| InterestExpenseNonOperating | 2.65M | |||
| InterestIncomeNonOperating | 3.16M | 4.21M | 1.78M | |
| OperatingIncome | -49.92M | -56.56M | -63.22M | -47.23M |
| OperatingExpense | 49.81M | 51.08M | 54.68M | 39.49M |
| ResearchAndDevelopment | 14.60M | 12.82M | 12.87M | 9.78M |
| SellingGeneralAndAdministration | 35.21M | 38.26M | 41.81M | 29.71M |
| SellingAndMarketingExpense | 13.27M | 13.32M | 14.99M | 11.81M |
| GeneralAndAdministrativeExpense | 21.95M | 24.94M | 26.82M | 17.89M |
| OtherGandA | 21.95M | 24.94M | 26.82M | 17.89M |
| GrossProfit | -109.00K | -5.49M | -8.54M | -7.74M |
| CostOfRevenue | 28.16M | 28.00M | 25.67M | 30.97M |
| TotalRevenue | 28.05M | 22.52M | 17.13M | 23.23M |
| OperatingRevenue | 28.05M | 22.52M | 17.13M | 23.23M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 43.04M | 42.41M | 42.09M | 41.47M |
| ShareIssued | 43.04M | 42.41M | 42.09M | 41.47M |
| TotalDebt | 6.17M | 7.35M | 7.97M | 0.00 |
| TangibleBookValue | 75.35M | 117.99M | 164.17M | 220.98M |
| InvestedCapital | 75.35M | 117.99M | 164.17M | 220.98M |
| WorkingCapital | 63.35M | 101.43M | 119.53M | 199.96M |
| NetTangibleAssets | 75.35M | 117.99M | 164.17M | 220.98M |
| CapitalLeaseObligations | 6.17M | 7.35M | 7.97M | 0.00 |
| CommonStockEquity | 75.35M | 117.99M | 164.17M | 220.98M |
| TotalCapitalization | 75.35M | 117.99M | 164.17M | 220.98M |
| TotalEquityGrossMinorityInterest | 75.35M | 117.99M | 164.17M | 220.98M |
| StockholdersEquity | 75.35M | 117.99M | 164.17M | 220.98M |
| GainsLossesNotAffectingRetainedEarnings | 39.00K | -101.00K | -1.11M | -16.00K |
| OtherEquityAdjustments | 39.00K | -101.00K | ||
| RetainedEarnings | -475.27M | -428.38M | -375.92M | -315.11M |
| AdditionalPaidInCapital | 550.16M | 546.05M | 540.77M | 535.69M |
| CapitalStock | 430.00K | 424.00K | 421.00K | 415.00K |
| CommonStock | 430.00K | 424.00K | 421.00K | 415.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 22.82M | 25.46M | 26.48M | 20.19M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 5.25M | 6.48M | 7.43M | 2.02M |
| OtherNonCurrentLiabilities | 298.00K | 263.00K | 229.00K | 1.21M |
| PreferredSecuritiesOutsideStockEquity | 0.00 | |||
| NonCurrentDeferredLiabilities | 0.00 | 813.00K | ||
| LongTermDebtAndCapitalLeaseObligation | 4.95M | 6.21M | 7.20M | 0.00 |
| LongTermCapitalLeaseObligation | 4.95M | 6.21M | 7.20M | 0.00 |
| CurrentLiabilities | 17.57M | 18.99M | 19.05M | 18.17M |
| OtherCurrentLiabilities | 152.00K | 141.00K | 520.00K | 338.00K |
| CurrentDeferredLiabilities | 6.60M | 5.97M | 4.71M | 3.44M |
| CurrentDeferredRevenue | 6.60M | 5.97M | 4.71M | 3.31M |
| CurrentDebtAndCapitalLeaseObligation | 1.21M | 1.13M | 766.00K | |
| CurrentCapitalLeaseObligation | 1.21M | 1.13M | 766.00K | 0.00 |
| PensionandOtherPostRetirementBenefitPlansCurrent | 4.46M | 4.81M | 3.22M | 3.57M |
| PayablesAndAccruedExpenses | 5.14M | 6.93M | 9.84M | 10.82M |
| CurrentAccruedExpenses | 2.37M | 4.71M | 4.08M | 6.10M |
| InterestPayable | 0.00 | |||
| Payables | 2.77M | 2.23M | 5.76M | 4.72M |
| TotalTaxPayable | 235.00K | 252.00K | 329.00K | 781.00K |
| AccountsPayable | 2.54M | 1.97M | 5.43M | 3.94M |
| TotalAssets | 98.17M | 143.45M | 190.65M | 241.17M |
| TotalNonCurrentAssets | 17.25M | 23.04M | 52.07M | 23.05M |
| OtherNonCurrentAssets | 896.00K | 1.05M | 1.40M | 1.77M |
| InvestmentsAndAdvances | 0.00 | 2.91M | 29.79M | 9.97M |
| InvestmentinFinancialAssets | 2.91M | 29.79M | ||
| NetPPE | 16.36M | 19.07M | 20.88M | 11.30M |
| AccumulatedDepreciation | -16.52M | -14.31M | -11.80M | -11.79M |
| GrossPPE | 32.88M | 33.38M | 32.68M | 23.09M |
| Leases | 9.18M | 8.55M | 8.26M | 3.01M |
| ConstructionInProgress | 1.59M | 2.29M | 1.71M | 4.31M |
| OtherProperties | 19.62M | 19.99M | 20.47M | 13.28M |
| MachineryFurnitureEquipment | 2.48M | 2.55M | 2.24M | 2.49M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 80.92M | 120.42M | 138.58M | 218.12M |
| OtherCurrentAssets | 843.00K | 577.00K | 705.00K | 440.00K |
| PrepaidAssets | 1.62M | 2.24M | 2.56M | 2.88M |
| Inventory | 20.20M | 19.96M | 21.19M | 15.67M |
| FinishedGoods | 9.27M | 6.94M | 4.57M | 4.30M |
| WorkInProcess | 372.00K | 150.00K | 1.60M | 1.24M |
| RawMaterials | 10.56M | 12.87M | 15.01M | 10.13M |
| Receivables | 7.53M | 5.58M | 5.48M | 5.63M |
| OtherReceivables | 6.00K | 51.00K | 112.00K | 627.00K |
| AccountsReceivable | 7.52M | 5.53M | 5.37M | 5.00M |
| CashCashEquivalentsAndShortTermInvestments | 50.73M | 92.05M | 108.65M | 193.50M |
| OtherShortTermInvestments | 33.82M | 67.77M | 81.58M | 15.11M |
| CashAndCashEquivalents | 16.91M | 24.29M | 27.06M | 178.39M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -45.52M | -46.93M | -65.29M | -58.18M |
| RepaymentOfDebt | -35.00K | -37.00K | -33.00K | -26.17M |
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 0.00 | 243.86M | ||
| CapitalExpenditure | -1.36M | -1.84M | -6.74M | -3.22M |
| InterestPaidSupplementalData | 40.00K | 38.00K | 42.00K | 2.59M |
| EndCashPosition | 17.28M | 24.57M | 27.35M | 178.67M |
| BeginningCashPosition | 24.57M | 27.35M | 178.67M | 30.18M |
| ChangesInCash | -7.29M | -2.78M | -151.32M | 148.49M |
| FinancingCashFlow | 203.00K | 149.00K | 693.00K | 216.75M |
| CashFlowFromContinuingFinancingActivities | 203.00K | 149.00K | 693.00K | 216.75M |
| NetOtherFinancingCharges | -1.87M | |||
| ProceedsFromStockOptionExercised | 238.00K | 186.00K | 726.00K | 926.00K |
| NetPreferredStockIssuance | 0.00 | 79.74M | ||
| PreferredStockIssuance | 0.00 | 79.74M | ||
| NetCommonStockIssuance | 0.00 | 164.11M | ||
| CommonStockIssuance | 0.00 | 164.11M | ||
| NetIssuancePaymentsOfDebt | -35.00K | -37.00K | -33.00K | -26.17M |
| NetLongTermDebtIssuance | -35.00K | -37.00K | -33.00K | -26.17M |
| LongTermDebtPayments | -35.00K | -37.00K | -33.00K | -26.17M |
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | 36.66M | 42.15M | -93.47M | -13.29M |
| CashFlowFromContinuingInvestingActivities | 36.66M | 42.15M | -93.47M | -13.29M |
| NetInvestmentPurchaseAndSale | 38.02M | 44.00M | -86.73M | -10.09M |
| SaleOfInvestment | 73.06M | 106.49M | 92.50M | 15.00M |
| PurchaseOfInvestment | -35.03M | -62.49M | -179.23M | -25.09M |
| NetPPEPurchaseAndSale | -1.36M | -1.84M | -6.74M | -3.20M |
| SaleOfPPE | 0.00 | 20.00K | ||
| PurchaseOfPPE | -1.36M | -1.84M | -6.74M | -3.22M |
| OperatingCashFlow | -44.15M | -45.08M | -58.55M | -54.96M |
| CashFlowFromContinuingOperatingActivities | -44.15M | -45.08M | -58.55M | -54.96M |
| ChangeInWorkingCapital | -4.77M | 555.00K | -5.33M | -8.00M |
| ChangeInOtherWorkingCapital | 626.00K | 1.27M | 1.40M | -1.01M |
| ChangeInOtherCurrentLiabilities | 0.00 | -30.00K | ||
| ChangeInOtherCurrentAssets | -150.00K | 5.00K | 179.00K | -851.00K |
| ChangeInPayablesAndAccruedExpense | -3.33M | -2.02M | -1.28M | 1.78M |
| ChangeInAccruedExpense | -3.89M | 1.43M | -2.76M | 2.31M |
| ChangeInPayable | 562.00K | -3.46M | 1.48M | -524.00K |
| ChangeInAccountPayable | 562.00K | -3.46M | 1.48M | -524.00K |
| ChangeInPrepaidAssets | 403.00K | 272.00K | 578.00K | -1.10M |
| ChangeInInventory | -335.00K | 1.19M | -5.84M | -6.77M |
| ChangeInReceivables | -1.99M | -163.00K | -364.00K | -17.00K |
| ChangesInAccountReceivables | -1.99M | -163.00K | -364.00K | -17.00K |
| OtherNonCashItems | 1.20M | 1.24M | 1.04M | 404.00K |
| StockBasedCompensation | 3.87M | 4.75M | 4.02M | 1.84M |
| ProvisionandWriteOffofAssets | 95.00K | 34.00K | 326.00K | 60.00K |
| AmortizationOfSecurities | -1.02M | -2.29M | -662.00K | -3.00K |
| DepreciationAmortizationDepletion | 3.36M | 3.10M | 2.84M | 1.53M |
| DepreciationAndAmortization | 3.36M | 3.10M | 2.84M | 1.53M |
| OperatingGainsLosses | 28.00K | 22.73M | ||
| GainLossOnInvestmentSecurities | 19.64M | |||
| GainLossOnSaleOfPPE | 0.00 | 28.00K | -18.00K | |
| NetIncomeFromContinuingOperations | -46.89M | -52.47M | -60.81M | -73.52M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for RPID
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|